BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peyclit L, Yousfi H, Rolain JM, Bittar F. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi. Pharmaceuticals (Basel) 2021;14:488. [PMID: 34065420 DOI: 10.3390/ph14050488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Papp Z, Borman AM, Forgács L, Kovács R, Tóth Z, Chun-Ju C, Kardos G, Juhász B, Szilvássy J, Majoros L. Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades. Pathogens 2021;10:990. [PMID: 34451454 DOI: 10.3390/pathogens10080990] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics 2022;11:718. [DOI: 10.3390/antibiotics11060718] [Reference Citation Analysis]
3 Kim JH, Cheng LW, Land KM. Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing. Pharmaceuticals 2022;15:787. [DOI: 10.3390/ph15070787] [Reference Citation Analysis]
4 El-ganiny AM, Kamel HA, Yossef NE, Mansour B, El-baz AM. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kovács R. Special Issue: Alternative Therapeutic Approaches of Candida Infections. JoF 2022;8:170. [DOI: 10.3390/jof8020170] [Reference Citation Analysis]
6 Jampilek J. Novel avenues for identification of new antifungal drugs and current challenges. Expert Opin Drug Discov 2022. [PMID: 35787715 DOI: 10.1080/17460441.2022.2097659] [Reference Citation Analysis]